XLV - IQVIA A Smart Choice In A High-Inflation Environment

April, 29 2022 11:54 AM SPDR Select Sector Fund - Health Care

IQVIA has the potential to outperform the market in a higher inflation environment.
Significant growth potential with projected 17.72% FCF and 11.68% EBIT CAGR over the next 5 years.
Decentralized clinical trials, the emergence of virtual trials, blockchain technologies, AI and ML applications are great future growth drivers.
Based on my valuation model, the stock has most likely a 28% upside potential with a price target at $282.

For further details see:

Company Name:	SPDR Select Sector Fund - Health Care
Stock Symbol:	XLV
Market:	NYSE